BCG Vaccination Linked to Lower SARS-CoV-2 Seroprevalence
TUESDAY, Nov. 24, 2020 -- History of Bacillus Calmette-Guérin (BCG) vaccination is associated with decreased seroprevalence of anti-severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) immunoglobulin G (IgG) among health care workers (HCWs), according to a study published online Nov. 19 in the Journal of Clinical Investigation.
Magali Noval Rivas, Ph.D., from Cedars-Sinai Medical Center in Los Angeles, and colleagues examined SARS-CoV-2 seroprevalence and collected medical questionnaires, including BCG vaccination status and preexisting demographic and clinical characteristics, from an observational cohort of HCWs. Data were included for 6,201 HCWs in a multisite Los Angeles health care organization.
The researchers found that 29.6 percent of the HCWs reported a history of BCG vaccination and 68.9 percent did not receive BCG vaccination. Among HCWs with a history of BCG vaccination, seroprevalence of anti-SARS-CoV-2 IgG and incidence of self-reported clinical symptoms associated with COVID-19 were significantly decreased compared with those without BCG vaccination. A history of BCG vaccination, but not meningococcal, pneumococcal, or influenza vaccination, was associated with reduced SARS-CoV-2 IgG seroconversion after adjustment for age and sex.
"Given our findings, we believe that large, randomized clinical trials are urgently needed to confirm whether BCG vaccination can induce a protective effect against SARS-CoV-2 infection," a coauthor said in a statement.
Abstract/Full Text (subscription or payment may be required)
© 2020 HealthDay. All rights reserved.
Posted: November 2020
Further Support and Information on COVID-19
Read this next
RSNA: Neurologic Complications of COVID-19 Examined
TUESDAY, Nov. 24, 2020 -- More than one-fifth of patients with COVID-19 presenting with neurologic findings who underwent neuroimaging had critical findings, according to a study...
SARS-CoV-2 Infection Rates Generally Low in U.S. Children
TUESDAY, Nov. 24, 2020 -- Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection rates are generally low among children, with variation in testing and positivity...
CDC Warns That COVID-19 Vaccine Might Spur Transient Sickness
TUESDAY, Nov. 24, 2020 -- At least three new COVID-19 vaccine candidates are already in the pipeline, with a roll-out expected early in the new year. But on Monday, experts...